MoonLake Immunotherapeuti...
(MLTX)
undefined
undefined%
At close: undefined
51.34
-0.10%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | - | - | - |
Cost of Revenue | 13.16K | 12.36K | 4.97K | - |
Gross Profit | -13.16K | -12.36K | -4.97K | - |
Operating Income | -54.12M | -65.06M | -53.58M | -105.76K |
Interest Income | - | - | - | 14.92K |
Pretax Income | -43.98M | -64.47M | -53.64M | -90.84K |
Net Income | -36.01M | -64.51M | -53.64M | -90.84K |
Selling & General & Admin | 22.32M | 23.01M | 18.05M | 105.75K |
Research & Development | 31.80M | 42.05M | 35.52M | - |
Other Expenses | - | 591.73K | - | - |
Operating Expenses | 54.12M | 65.06M | 53.57M | 105.75K |
Interest Expense | - | - | - | - |
Selling & Marketing Expenses | - | - | 18.03M | - |
Cost & Expenses | 54.12M | 65.06M | 53.58M | 105.75K |
Income Tax | 94.39K | 36.37K | 4.75K | -206.30K |
Shares Outstanding (Basic) | 49.12M | 29.36M | 7.84M | 14.80M |
Shares Outstanding (Diluted) | 49.12M | 29.36M | 7.84M | 14.80M |
EPS (Basic) | -0.73 | -2.2 | -6.84 | -0.01 |
EPS (Diluted) | -0.73 | -2.2 | -6.84 | -0.01 |
EBITDA | -54.11M | -65.05M | -53.63M | -90.84K |
Depreciation & Amortization | 13.16K | 12.36K | 4.97K | 206.30K |